Vimarsana
Biggest News Aggregation in the World

Page 45 - Medication Guide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medication Guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medication Guide Today - Breaking & Trending Today

Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference - Vimarsana News

Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference

Published: May 9, 2023

First study to assess histologic changes in the kidneys of patients with lupus nephritis treated with LUPKYNIS® Treatment was not associated with chronic injury, with the average chronicity... | May 9, 2023

Source: marketscreener.com
Related Topics:
United StatesUnited KingdomGreat BritainGreg KeenanEuropean UnionAurinia Pharmaceuticals IncAurinia PharmaceuticalsAurinia Pharma Us IncClinical Rheumatology East Conference MayChief Medical OfficerInvestor RelationsRed Cell AplasiaDrug InteractionsModerate Hepatic ImpairmentPrescribing InformationBoxed WarningMedication GuideAurinia Pharmaceuticals Inc Stock ExchangePress ReleaseVerage Auph Ca05156v1022
ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting - Vimarsana News

ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting

Published: May 9, 2023

WALTHAM, Mass.--(BUSINESS WIRE)--May 9, 2023--

Source: wsiltv.com
Related Topics:
University Of OklahomaUnited StatesKathleen MooreAnna BerkenblitCourtney OkonekRobert StanislaroDavid OmalleyMirvetuximab SoravtansinePivekimab SunirineAnabel ChanClinical ResearchExchange CommissionDepartment Of LeukemiaImmunogen IncJames Cancer CenterAmerican Society Of Clinical OncologyCompany Quarterly Report On FormOhio State UniversityExchange Commision OnCompany Annual Report On FormSarah Cannon Phasei ProgramExchange Commission OnUniversity Of Texas Md Anderson Cancer CenterClinical OncologyAnnual Meeting
Guerbet Announces ACR Committee on Drugs and Contrast Media Classifies Elucirem™ (Gadopiclenol) Injection a Group II Agent - Vimarsana News

Guerbet Announces ACR Committee on Drugs and Contrast Media Classifies Elucirem™ (Gadopiclenol) Injection a Group II Agent

Published: May 9, 2023

/PRNewswire/ -- Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today that based on the most recent...

Source: prnewswire.com
Related Topics:
North CarolinaUnited StatesLe GreneurJared HoukEdie ElkinsonLeeann EssaiEuropean Medicines AgencySyneos HealthCommittee On DrugsGuerbet GroupNovel New MacrocyclicContrast Enhanced Magnetic Resonance ImagingContrast MediaCommercial Vice PresidentEuronext ParisCentral Nervous SystemMagnetic Resonance ImagingFull Text ViewBody Magnetic Resonance ImagingText ViewEuropean MedicinesImportant SafetySystemic FibrosisKidney InjuryInjection Site Reactions
AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week® - Vimarsana News

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

Published: May 6, 2023

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will present 29 abstracts during the 2023 Digestive Disease Week (DDW) Annual Meeting, May 6-9, 2023,...

Source: prnewswire.com
Related Topics:
United StatesUpadacitinib PharmacokineticCeline GoldbergerSociety For Surgery Of The Alimentary TractExchange CommissionBoehringer IngelheimAbbvie IncAmerican Society For Gastrointestinal EndoscopyMotility Disorders Research ForumDrug AdministrationAmerican Gastroenterological AssociationIronwood PharmaceuticalsClinical Trials To Guide Care Research ForumResearch ForumDisease WeekAnnual MeetingReal World DataClinical TrialsGuide CareImproves Endoscopic OutcomesSeverely Active CrohnDisease IrrespectivePrevious FailureClinical RespondersDisease Receiving
I Found the Right Injectable to Complement My Skin Regimen - Vimarsana News

I Found the Right Injectable to Complement My Skin Regimen

Published: May 5, 2023

Influencer Laticia Rolle on stepping up her approach to aging.

Source: goodhousekeeping.com
Related Topics:
New YorkUnited StatesLaticia RolleGua ShaJennifer LevineNicole CataneseMerz North America IncNew York CityHow Xeomin Has Made My RegimenBefore XeominMedication GuideImportant Safety InformationFull Prescribing InformationNorth America